title: The use of recombinant factor VIIa in severe postpartum hemorrhage.
authors.affiliation: Barzilai Medical Center, Ashkelon, Israel.
authors.forename: Shmuel
authors.initials: S
authors.lastname: Segal
authors.forename: Iftah Y
authors.initials: IY
authors.lastname: Shemesh
authors.forename: Rima
authors.initials: R
authors.lastname: Blumental
authors.forename: Boris
authors.initials: B
authors.lastname: Yoffe
authors.forename: Neri
authors.initials: N
authors.lastname: Laufer
authors.forename: David
authors.initials: D
authors.lastname: Mankuta
authors.forename: Moshe
authors.initials: M
authors.lastname: Mazor
authors.forename: Shifra
authors.initials: S
authors.lastname: Zohar
authors.forename: Eyal
authors.initials: E
authors.lastname: Schiff
authors.forename: Uri
authors.initials: U
authors.lastname: Martinovitz
mesh_terms: D015942:Factor VIIa / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006487:Hemostasis; D006801:Humans; D006473:Postpartum Hemorrhage / Q000188:drug therapy* / Q000473:pathology; D011247:Pregnancy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D015942:Factor VIIa